Exascale Labs Holdings Inc. Class A Common Stock
XLABRank #107Updated . Prices are snapshots and may be delayed.
Exascale Labs Holdings Inc. Class A Common Stock price chart
AI Outlook for Exascale Labs Holdings Inc. Class A Common Stock
Neutral posture- Long-term trend-63.3% vs 200-day average
- Medium-term trend-11.3% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Exascale Labs Holdings Inc. Class A Common Stock performance
About Exascale Labs Holdings Inc. Class A Common Stock
Exascale Labs Holdings Inc. Class A Common Stock is a n/a company based in the United States, listed on NASDAQ since 2025 (ticker XLAB).
Its market capitalisation is $87 million, the #107 largest of the 124 stocks Air Radar has market-cap data for. The shares trade at a price-to-earnings ratio of 8.3.
Exascale Labs Holdings Inc. Class A Common Stock market data
What is the price of Exascale Labs Holdings Inc. Class A Common Stock today?
Exascale Labs Holdings Inc. Class A Common Stock (XLAB) is at $2.35, +27.37% on the day.
What is the 52-week range of Exascale Labs Holdings Inc. Class A Common Stock?
Over the past year Exascale Labs Holdings Inc. Class A Common Stock has traded between $0.7777 and $7.39. It is currently 24% of the way up that range.
What is the market cap of Exascale Labs Holdings Inc. Class A Common Stock?
Exascale Labs Holdings Inc. Class A Common Stock has a market capitalisation of $87,495,313, the #107 largest of the stocks Air Radar has market-cap data for.
What is the P/E ratio of Exascale Labs Holdings Inc. Class A Common Stock?
Exascale Labs Holdings Inc. Class A Common Stock trades at a price-to-earnings ratio of 8.3.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.





